These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10927753)

  • 21. Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Halperin JL; Hankey GJ; Wojdyla DM; Piccini JP; Lokhnygina Y; Patel MR; Breithardt G; Singer DE; Becker RC; Hacke W; Paolini JF; Nessel CC; Mahaffey KW; Califf RM; Fox KA;
    Circulation; 2014 Jul; 130(2):138-46. PubMed ID: 24895454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.
    Palamaner Subash Shantha G; Bhave PD; Girotra S; Hodgson-Zingman D; Mazur A; Giudici M; Chrischilles E; Vaughan Sarrazin MS
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28408716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and safety of low intensity warfarin therapy in Chinese elderly atrial fibrillation patients with high CHADS2 risk score.
    Wu J; Wang J; Jiang S; Xu J; Di Q; Zhou C; Min X; Pang S; Wang H; Xu D; Guo Y
    Int J Cardiol; 2013 Sep; 167(6):3067-8. PubMed ID: 23200268
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of new oral anticoagulants in patients with atrial fibrillation previously treated with warfarin: a meta-analysis of randomized controlled trials.
    Fauchier L; Clementy N; Saint-Etienne C; Simeon E; Angoulvant D; Bernard-Brunet A
    Int J Cardiol; 2014 Apr; 173(1):122-4. PubMed ID: 24636544
    [No Abstract]   [Full Text] [Related]  

  • 25. Possible limitations of using the HAS-BLED bleeding score in real life settings.
    Gulec S
    Thromb Res; 2014 Jun; 133(6):959-60. PubMed ID: 24525313
    [No Abstract]   [Full Text] [Related]  

  • 26. Warfarin can be safe and effective in the extreme elderly.
    Khan S; Myers K
    Age Ageing; 2009 Nov; 38(6):763; author reply 763-4. PubMed ID: 19749202
    [No Abstract]   [Full Text] [Related]  

  • 27. Dual antiplatelet therapy versus warfarin anticoagulation in patients undergoing catheter ablation of atrial fibrillation.
    Ling Z; Jia F; Xu Y; Su L; Liu Z; Du H; Yang X; Lan X; Xiao P; Chen W; Fan J; Luo S; Yin Y; Nazarian S
    Int J Cardiol; 2014 May; 173(2):345-6. PubMed ID: 24679686
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anticoagulation therapy of atrial fibrillation].
    Gjesdal K
    Tidsskr Nor Laegeforen; 2002 Jan; 122(2):191-2. PubMed ID: 11873577
    [No Abstract]   [Full Text] [Related]  

  • 29. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 30. Toward a more practical decision analysis: a patient's perspective.
    Parducci A
    West J Med; 2001 May; 174(5):316-7. PubMed ID: 11342504
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
    J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin for Preventing Further Cerebral Microbleeds in Acute Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation and At Least One Microbleed: CMB-NOW Multisite Pilot Trial.
    Yokoyama M; Mizuma A; Terao T; Tanaka F; Nishiyama K; Hasegawa Y; Nagata E; Nogawa S; Kobayashi H; Yanagimachi N; Okazaki T; Kitagawa K; Takizawa S;
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1918-1925. PubMed ID: 31005561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulation for atrial fibrillation: should warfarin be temporarily stopped or continued after acute cardioembolic stroke?
    Mudd PD; James MA
    Age Ageing; 2010 Nov; 39(6):670-3. PubMed ID: 20858671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term anticoagulation in atrial fibrillation. Individualized therapy in the era of new oral anticoagulants].
    Füeßl HS
    MMW Fortschr Med; 2014 Oct; 156(18):22-4. PubMed ID: 25464533
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral anticoagulant therapy in patients with atrial fibrillation.
    Pengo V
    Semin Vasc Med; 2003 Aug; 3(3):333-8. PubMed ID: 15199467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Primary and secondary prevention of cardiogenic cerebral embolism].
    Hori M
    No To Shinkei; 2006 Oct; 58(10):843-8. PubMed ID: 17087275
    [No Abstract]   [Full Text] [Related]  

  • 37. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
    J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Warfarin: better the devil you know.
    Blockman M
    Cardiovasc J Afr; 2017; 28(6):344-345. PubMed ID: 29297543
    [No Abstract]   [Full Text] [Related]  

  • 39. Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery.
    Schulman S; Cybulsky I; Delaney J
    Thromb Res; 2015 May; 135(5):841-5. PubMed ID: 25776468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anticoagulation in atrial fibrillation].
    Burkhard-Meier C; Deutsch HJ; Erdmann E
    Dtsch Med Wochenschr; 2000 Oct; 125(42):1267-71. PubMed ID: 11098239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.